Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
| Mylan Pharmaceuticals, Inc. |
| Novo Nordisk, Inc. and Novo Nordisk, A/S |
| 1:2022cv00023 |
| March 18, 2022 |
| US District Court for the Northern District of West Virginia |
| John Preston Bailey |
| Irene M Keeley |
| Patent |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 16, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 27 REPORT of Rule 26(f) Planning Meeting. (White, Brandon) |
| Filing 26 NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Pharmaceuticals, Inc. (Copland, Gordon) |
| Filing 25 Courtesy copy of Corrected Schedule of Actions and Proof of Service Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Exhibit 1 to Corrected Schedule of Actions, #2 Exhibit 2 to Corrected Schedule of Actions, #3 Exhibit 3 to Corrected Schedule of Actions, #4 Exhibit 4 to Corrected Schedule of Actions, #5 Exhibit 5 to Corrected Schedule of Actions, #6 Exhibit 6 to Corrected Schedule of Actions, #7 Attachment Corrected Proof of Service)(Companion, James) |
Filing 24
ORDER EXTENDING DEADLINE re #23 . The Court hereby ORDERS that the parties may submit their Joint Report of Initial Planning Meeting through and until May 16, 2022. Signed by District Judge John Preston Bailey on 5/9/2022. (dk)
|
| Filing 23 Joint MOTION for Extension of Deadline to File the Joint Report of Initial Planning Meeting by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
| Filing 22 Courtesy copy of Motion to Transfer Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Attachment Opening Brief to Motion to Transfer, #2 Attachment Schedule of Actions, #3 Exhibit 1 to Schedule of Actions, #4 Exhibit 2 to Schedule of Actions, #5 Exhibit 3 to Schedule of Actions, #6 Exhibit 4 to Schedule of Actions, #7 Exhibit 5 to Schedule of Actions, #8 Exhibit 6 to Schedule of Actions, #9 Attachment Proof of Service, #10 Attachment Oral Argument Statement)(Companion, James) |
| Filing 21 PLAINTIFFS' ANSWER to #19 Answer to Complaint, Counterclaim by Novo Nordisk, A/S, Novo Nordisk, Inc..(Companion, James) |
| Filing 20 Corporate Disclosure Statement by Mylan Pharmaceuticals, Inc.. (White, Brandon) |
| Filing 19 ANSWER to #2 Complaint,, , COUNTERCLAIM against All Plaintiffs by Mylan Pharmaceuticals, Inc..(White, Brandon) |
|
Filing 18
ORDER granting #12 Motion for Leave to Appear Pro Hac Vice of Ryan Johnson. Signed by District Judge John Preston Bailey on 03/29/2022. (kam)
|
|
Filing 17
ORDER granting #11 Motion for Leave to Appear Pro Hac Vice of Jeffrey Oelke. Signed by District Judge John Preston Bailey on 03/29/2022. (kam)
|
|
Filing 16
ORDER granting #10 Motion for Leave to Appear Pro Hac Vice of Robert Counihan. Signed by District Judge John Preston Bailey on 03/29/2022. (kam)
|
|
Filing 15
ORDER granting #9 Motion for Leave to Appear Pro Hac Vice of Laura Moran. Signed by District Judge John Preston Bailey on 03/29/2022. (kam)
|
| Filing 14 Pro Hac Vice filing fee: $ 800.00, receipt number WVNC003403 as to attorneys L. Morgan, R. Johnson, J. Oelke, and R. Counihan. (kam) |
| Filing 13 WAIVER OF SERVICE Returned Executed by Novo Nordisk, A/S, Novo Nordisk, Inc.. Mylan Pharmaceuticals, Inc. waiver sent on 3/24/2022, answer due 5/23/2022. (Companion, James) |
| Filing 12 MOTION for Leave to Appear Pro Hac Vice of Ryan Johnson by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
| Filing 11 MOTION for Leave to Appear Pro Hac Vice of Jeffrey Oelke by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
| Filing 10 MOTION for Leave to Appear Pro Hac Vice of Robert Counihan by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
| Filing 9 MOTION for Leave to Appear Pro Hac Vice of Laura Moran by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
|
Filing 8
FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 4/25/2022. Rule 26 Meeting Report due by 5/9/2022. Discovery due by 5/23/2022. Signed by District Judge John Preston Bailey on 3/28/2022. (dk)
|
|
Filing 7
ORDER. Case reassigned to District Judge John Preston Bailey for all further proceedings. Senior Judge Irene M. Keeley no longer assigned to case. Signed by Senior Judge Irene M. Keeley on 03/25/2022. (kam)
|
| Filing 6 Supplemental ANDA Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Companion, James) |
| Filing 5 Disclosure Statement Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Companion, James) |
| Filing 4 VERIFICATION OF ATTORNEY ADMISSION to Attorneys J. Oelke, L. Moran, R. Johnson, and R. Counihan. (to Oelke, Moran, and Johnson by NEF; to R. Counihan by U.S. mail) (dk) |
| Filing 3 REPORT to USPTO on the filing or determination of an action regarding re #2 Complaint. (dk) |
| Filing 2 COMPLAINT against Mylan Pharmaceuticals, Inc., filed by Novo Nordisk, A/S, Novo Nordisk, Inc. Filing Fee Paid $402. Receipt #AWVNDC-3445410. (Attachments: #1 Exhibit A - 833 Patent, #2 Exhibit B - 343 Patent, #3 Exhibit C - 122 Patent, #4 Exhibit D - 969 Patent, #5 Exhibit E - 383 Patent, #6 Exhibit F - 002 Patent, #7 Exhibit G - 239 Patent, #8 Exhibit H - 154 Patent, #9 Exhibit I - 180 Patent, #10 Exhibit J - 611 Patent, #11 Exhibit K - 953 Patent, #12 Exhibit L - 757 Patent, #13 Exhibit M - 155 Patent, #14 Exhibit N - 462 Patent, #15 Exhibit O - 616 Patent, #16 Exhibit P - 652 Patent, #17 Exhibit Q - 063 Patent, #18 Exhibit R - 363 Patent, #19 Civil Cover Sheet)(dk) |
| Filing 1 REPORT ON FILING ACTION RE PATENT Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Companion, James) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
